参芪降糖颗粒辅助治疗2 型糖尿病伴代谢综合征临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:


Clinical Study on Shenqi Jiangtang Granules in Adjuvant Therapy of Type II Diabetes Complicated with Metabolism Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察参芪降糖颗粒辅助治疗2 型糖尿病伴代谢综合征的临床疗效。方法:采用随机数字表 法将103 例2 型糖尿病伴代谢综合征患者分为对照组(51 例) 与观察组(52 例)。对照组接受常规西药治疗, 观察组在对照组基础上加用参芪降糖颗粒治疗。比较2 组治疗前后血糖指标、中医证候评分、血脂指标、胰岛 β 细胞功能指标,并评估2 组临床疗效及不良反应发生情况。结果:治疗后,观察组总有效率92.31%,高于 对照组76.47%(P<0.05)。2 组治疗后空腹血糖(FBG)、餐后2 h 血糖(P2hBG)、糖化血红蛋白(HbA1c)、 总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C) 水平均低于治疗前(P<0.05),高密度脂 蛋白胆固醇(HDL-C) 水平高于治疗前(P<0.05);观察组治疗后血糖指标、TC、TG、LDL-C 水平低于对照 组(P<0.05),HDL-C 水平高于对照组(P<0.05)。治疗后,2 组胰岛β 细胞功能指数(HOMA-β) 水平较治 疗前升高(P<0.05),中医证候评分、胰岛素抵抗指数(HOMA-IR) 降低(P<0.05);观察组治疗后HOMA-β 水平高于对照组(P<0.05),中医证候评分、HOMA-IR 水平低于对照组(P<0.05)。2 组不良反应发生率比 较,差异无统计学意义(P>0.05)。结论:参芪降糖颗粒辅助治疗2 型糖尿病伴代谢综合征疗效确切,能有效 改善患者血脂紊乱与胰岛β 细胞功能,降低血糖水平,安全性较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Shenqi Jiangtang Granules in adjuvant therapy of type Ⅱ diabetes complicated with metabolism syndrome. Methods: A total of 103 patients with type Ⅱ diabetes complicated with metabolism syndrome were divided into the control group and the observation group according to the random number table method, with 51 and 52 cases in each group. The control group was given routine western medicine for treatment, and the observation group was additionally treated with Shenqi Jiangtang Granules based on the treatment of the control group. Before and after treatment, the indexes of blood glucose, the traditional Chinese medicine (TCM) syndrome scores, indexes of blood lipid,and indexes of islet β-cell function were compared between the two groups;the clinical effects and incidence of adverse reactions in the two groups were evaluated. Results: After treatment,the total effective rate was 92.31% in the observation group,higher than that of 76.47% in the control group (P<0.05). After treatment,the levels of fasting blood glucose (FBG),2-hour post-breakfast blood glucose (P2hBG) and hemoglobin A1c (HbA1c), total cholesterol (TC), triglyceride (TG) and lowdensity lipoprotein-cholesterol (LDC-C) in both groups were lower than those before treatment (P<0.05), the high-density lipoprotein cholesterol (HDL-C) levels were higher than those before treatment (P<0.05); the levels of indexes of blood glucose,TC,TG and LDL-C in the observation group were lower than those in the control group (P<0.05), and the HDL- C level was higher than that in the control group (P<0.05). After treatment,the the index of homeostatic model assessment for β cell function (HOMA- β) levels in both groups were increased when compared with those before treatment (P<0.05), and the TCM syndrome scores and homeostatic model assessment of insulin resistance (HOMA- IR) levels were decreased (P<0.05); the HOMA- β level in the observation group was higher than that in the control group (P<0.05),and the TCM syndrome scores and HOMA-IR level were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups (P>0.05). Conclusion: Shenqi Jiangtang Granules as an adjuvant therapy has a definite curative effect on type II diabetes complicated with metabolism syndrome, which can effectively improve the disorder of blood lipid and islet β-cell function of patients,and reduce the level of blood glucose with good safety.

    参考文献
    相似文献
    引证文献
引用本文

吴奇红.参芪降糖颗粒辅助治疗2 型糖尿病伴代谢综合征临床研究[J].新中医,2023,55(13):85-89

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-14
  • 出版日期:
文章二维码